期刊文献+

盐酸雷莫司琼口腔崩解片预防恶性血液疾病联合化疗所致的胃肠反应 被引量:1

Clinical evaluation of ramosetron hydrochloride disintegrating buccal tablet in the prevention of gastrointestinal reaction induced by combined chemotherapy in patients with malignant blood diseases
下载PDF
导出
摘要 目的:观察盐酸雷莫司琼口腔崩解片预防恶性血液疾病患者联合化疗所致胃肠反应的疗效和安全性。方法:采用随机、对照方法,将入选病例随机分为治疗组(含服盐酸雷莫司琼口腔崩解片0.1mg)和对照组(静脉注射盐酸托烷司琼5mg)。结果:可评价疗效及安全性病例110例。两种药物对控制化疗所致食欲缺乏、恶心和呕吐的有效率相似。第1~7天盐酸雷莫司琼对食欲缺乏的完全控制率(52.7%~63.6%)、第4~7天对恶心的完全控制率(43.6%~56.4%)及第3、4、6天对呕吐的完全控制率(80.0%、87.3%和90.9%)明显优于盐酸托烷司琼注射剂,差异有显著性(P〈0.05)。盐酸雷莫司琼不良反应轻,主要为便秘、头痛、体热感和疲倦,为一过性,其发生率与盐酸托烷司琼注射剂相似。结论:盐酸雷莫司琼口腔崩解片能有效预防恶性血液病患者联合化疗所致的胃肠反应,适用于因各种原因不能吞服药片的患者。 Objective: To observe the efficacy and safety of ramosetron hydrochloride disintegrating buccal tablet (RHDBT) in the prophylaxis of gastrointestinal reaction induced by combined chemotherapy in patients with malignant blood diseases. Methods: A randomized controlled study was conducted. All the patients were randomized into treatment group (given RHDBT 0.1 mg ) or control group (given tropisetron hydrochloride 5 mg, iv). Results: A total of 110 patients were enrolled. RHDBT was as effective as tropisetron hydrochloride in the prophylaxis of anorexia, nausea and vomiting. The overall control rates of anorexia from day 1 to day 7 (52.7%-63.6%), of nausea from day 4 to day 7 (43.6%-56.4%) and of vomiting on day 3, day 4 and day 6 (80.0%, 87.3% and 90.9%) of RHDBT were higher than those of tropisetron hydrochloride(P〈0.05). The side effects of RHDBT were mild, including constipation, headache and fatigue,which were comparable with those of tropisetron hydrochloride in their frequencies. Conclusion: RHDBT is effective to prevent gastrointestinal reaction induced by combined chemotherapy in patients with malignant blood diseases. It is very convenient for patients who can not swallow tablets for various reasons.
出处 《药学服务与研究》 CAS CSCD 2008年第1期14-17,共4页 Pharmaceutical Care and Research
关键词 盐酸雷莫司琼 崩解片 盐酸托烷司琼 胃肠反应 血液肿瘤 药物疗法 联合 ramosetron hydrochloride disintegrating buccal tablet tropisetron hydrochloride grastrointestinal reaction hematologic neoplasms drug therapy, combination
  • 相关文献

参考文献6

  • 1Tsukagoshi S. A new antiemetic ramosetron hydrochloride [J]. Gan To Kagaku Ryoho,1997,24(3) :371-380.
  • 2李泽辉,杨栋林,王建祥,邱录贵,竺晓凡,肖志坚,韩明哲.奈西雅预防恶性血液病患者联合化疗所致胃肠反应的临床研究[J].天津药学,2001,13(5):39-42. 被引量:2
  • 3SHI Yuan-kai, HE Xiao-hui, YANG Sheng, et al. Ramosetron versus ondansetron in the prevention of chemotherapy-induced gastrointestinal side effects: a prospective randomized controlled studv[J]. Chemot heraov,2007,53( 1 ): 44-50
  • 4Yano S, Makino K, Nakamura H, et al. Comparative clinical study of the anti-emetic effects of oral ramosetron and injected granisetron in patients with malignant glioma undergoing ACNU chemotherapy[J]. Neurol Med Chir (Tokyo),2005,45 (6):294-299.
  • 5Tantipalakorn C, Srisomboon J, Thienthong H, et al. Comparison of oral versus intravenous ramosetron in prevention of acute cisplatin-induced emesis: a randomized controlled trial [J].J Med Assoc Thai,2004,87(2):119-125.
  • 6张频,冯奉仪,何友兼,李宇红,周美珍,程刚,陈岩.奈西雅崩解片预防抗肿瘤药物所致急性胃肠反应的临床研究[J].中华肿瘤杂志,2002,24(5):504-507. 被引量:4

二级参考文献4

  • 1Noda K,Ikeda M, Taguchi T, et al. Clinical evaluation of YM060 oral preparation in the treatment of nause and vomiting induced by the anticancer drug cisplatin: a phaseIII double-blind comparative study with ondansetron hydrochloride. J New Remed Clin,1996,45:1445-1462.
  • 2Nakamura E, Imasaki H, Takeshige T, et al. Metabolic rate of ramosetron hydrochloride(2): absorption, distribution and excretion after oral administration of 14 C-ramosetron hydrochloride to rats. Xenob Metab Distrib, 1995,10:808-818.
  • 3张频,冯奉仪,何友兼,李宇红,周美珍,程刚,李琳.奈西雅注射剂预防化疗药物所致胃肠反应的临床研究[J].中华肿瘤杂志,2000,22(1):70-73. 被引量:17
  • 4张频,冯奉仪,罗健,许建萍,王海燕,张长弓.雷莫司琼预防化疗药物所致胃肠反应的临床结果[J].实用肿瘤杂志,2000,15(4):237-239. 被引量:5

共引文献4

同被引文献10

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部